On the same day that FDA Commissioner Martin Makary spoke in a fireside chat during the 2025 Biotechnology Innovation Organization’s International Convention, the agency unveiled a pilot ...

The U.K.-based biotech is set to enter mid-stage studies for its depression drug this year, while two other GABAA modulators ...

Indeed, non-uniform uptake of systemically administered antibody is generally observed in biopsied specimens of solid tumors. While inhomogenous tumor antigen expression can be a factor ...

DelveInsight's Major Depressive Disorder pipeline report depicts a robust space with 75+ active players working to develop ...

So here’s the scoop: GABA has quietly landed in Dubai Marina, and it’s already feeling like that place you want to gatekeep (but won’t, because your friends deserve this too). By day ...

Dr. Michael Mina, an infectious disease and vaccination expert, emphasized the need for effective treatments and the benefits of a monoclonal antibody approach, which can rapidly stop infection ...

The FDA has turned down a pair of marketing applications for Regeneron’s CD20xCD3 bispecific antibody odronextamab to treat two common forms of non-Hodgkin lymphoma (NHL). The decision throws a ...

Three principal thyroid autoantigens are involved in AITD. These are thyroperoxidase (TPO), thyroglobulin (Tg) and the TSH receptor. Other autoantigens, such as the Sodium Iodide Symporter (NIS ...